Drug Trial Radar · NCT04146051
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
Last checked: Nov 20, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Dec 4, 2019
Primary completion
Jan 5, 2026
Study completion Sep 30, 2026
Sponsor
- Lead sponsor
- Cartesian TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 31, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase IIb study to evaluate the safety and preliminary efficacy of Descartes-08 CAR T-cells in patients with Generalized Myasthenia Gravis
Conditions
- Myasthenia Gravis, Generalized
Interventions
Descartes-08Drug
Autogolous T-cells expressing a chimeric antigen receptor directed to BCMA
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients with MG Composite improvement of ≥5 points.Time frame: Day 0 to Day 85
Locations
15 sites in 2 countries. Site status is shown where the registry gives one.
Profound Research
Carlsbad, California
University of California Irvine
Irvine, California
University of Colorado Anschutz Medical Campus
Aurora, Colorado
SFM Clinical Research, LLC
Boca Raton, Florida
Neurology Associates, P.A.
Orlando, Florida
University of South Florida
Tampa, Florida
University of Augusta
Augusta, Georgia
University of Kansas Medical Center Research Institute
Kansas City, Kansas
Dent Neurologic Institute
Amherst, New York
University of North Carolina
Chapel Hill, North Carolina
Oregon Health & Science University
Portland, Oregon
University of Pennsylvania
Philadelphia, Pennsylvania
Allegheny Health Network
Pittsburgh, Pennsylvania
Virginia Commonwealth University
Richmond, Virginia
University of Alberta
Edmonton, Alberta, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.